Moneycontrol PRO

business

To buy 1-2% of $70 bn Japanese pharma mkt: Elder

Elder Pharmaceuticals recently received an accreditation from the Ministry of Health, Japan for their API plant in Maharashtra. In an exclusive interview with CNBC-TV18, Alok Saxena, Director of Elder Pharmaceuticals says that the accreditation is going to help enter grow in the Japanese pharma market.

first published: Jan 4, 2011 05:01 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347